Real-world application of amikacin liposome inhalation in managing complex mycobacterium avium pulmonary conditions

被引：0
|
作者：
Yanagihara, Toyoshi [1 ]
Mori, Asami [2 ]
Ogata, Hiroaki [1 ]
Kadowaki, Masako [3 ]
Moriuchi, Yuki [1 ]
Ishimatsu, Akiko [1 ]
Otsuka, Junji [1 ]
Taguchi, Kazuhito [1 ]
Moriwaki, Atsushi [1 ]
Yoshida, Makoto [1 ]
机构：
[1] NHO Fukuoka Natl Hosp, Dept Resp Med, Fukuoka, Japan
[2] NHO Fukuoka Natl Hosp, Dept Pharm, Fukuoka, Japan
[3] NHO Fukuoka Natl Hosp, Dept Infect Dis, Fukuoka, Japan
来源：
RESPIROLOGY | 2024年 / 29卷
关键词：
D O I：
暂无
中图分类号：
R56 [呼吸系及胸部疾病];
学科分类号：
摘要：
AP15-006
引用
收藏
页码：223 / 223
页数：1
相关论文
共 50 条
  • [1] Real-World Outcomes of Amikacin Liposome Inhalation Suspension for Refractory Mycobacterium avium Complex Pulmonary Disease
    Kim, Bo-Guen
    Kim, Sae Rom
    Jhun, Byung Woo
    TUBERCULOSIS AND RESPIRATORY DISEASES, 2024, 87 (02) : 202 - 205
  • [2] Amikacin Liposome Inhalation Suspension in the Real-World Management of Refractory Mycobacterium avium Complex Pulmonary Disease
    Yanagihara, Toyoshi
    Ogata, Hiroaki
    Mori, Asami
    Kadowaki, Masako
    Moriuchi, Yuki
    Ishimatsu, Akiko
    Otsuka, Junji
    Taguchi, Kazuhito
    Moriwaki, Atushi
    Yoshida, Makoto
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2024, 16 (03)
  • [3] Effects of Amikacin Liposome Inhalation Suspension and Amikacin Resistance Development in Patients With Refractory Mycobacterium avium Complex Pulmonary Disease
    Kurahara, Yu
    Yoshida, Shiomi
    Osugi, Asami
    Tanaka, Yuya
    Kobayashi, Takehiko
    Mitsuhashi, Toshiharu
    Kawasaki, Yohei
    Mitarai, Satoshi
    Tsuyuguchi, Kazunari
    OPEN FORUM INFECTIOUS DISEASES, 2025, 12 (03):
  • [4] Amikacin Liposome Inhalation Suspension: A Review in Mycobacterium avium Complex Lung Disease
    Matt Shirley
    Drugs, 2019, 79 : 555 - 562
  • [5] Amikacin Liposome Inhalation Suspension: A Review in Mycobacterium avium Complex Lung Disease
    Shirley, Matt
    DRUGS, 2019, 79 (05) : 555 - 562
  • [6] Acquisition of Amikacin Resistance during Amikacin Liposome Inhalation Suspension Add-on Therapy for Mycobacterium avium Complex Pulmonary Disease
    Sano, Hirohito
    Fujino, Naoya
    Numakura, Tadahisa
    Yamada, Mitsuhiro
    Tode, Naoki
    Sugiura, Hisatoshi
    ANNALS OF THE AMERICAN THORACIC SOCIETY, 2024, 21 (03) : 526 - 529
  • [7] Correction to: Amikacin Liposome Inhalation Suspension: A Review in Mycobacterium avium Complex Lung Disease
    Matt Shirley
    Drugs, 2019, 79 : 791 - 791
  • [8] Amikacin liposome and Mycobacterium avium complex: A systematic review
    Zangiabadian, Moein
    Malekshahian, Donya
    Arabpour, Erfan
    Abadi, Sahel Shafiee Dolat
    Yazarlou, Fartous
    Bostanghadiri, Narjess
    Centis, Rosella
    Aghababa, AmirHossein Akbari
    Farahbakhsh, Mohammad
    Nasiri, Mohammad Javad
    Sotgiu, Giovanni
    Migliori, Giovanni Battista
    PLOS ONE, 2022, 17 (12):
  • [9] Effectiveness of Amikacin liposome inhalation suspension for refractory Mycobacterium avium complex pulmonary disease at 6 months post initiation
    Urabe, Naohisa
    Sakamoto, Susumu
    Tokita, Nozomi
    Yoshida, Hiromichi
    Usui, Yusuke
    Shimizu, Hiroshige
    Sekiya, Muneyuki
    Miyoshi, Shion
    Nakamura, Yasuhiko
    Isobe, Kazutoshi
    Kishi, Kazuma
    BMC PULMONARY MEDICINE, 2024, 24 (01):
  • [10] Amikacin liposome inhalation suspension as a treatment for patients with refractory mycobacterium avium complex lung infection
    Zhang, Yang
    Hill, Adam T.
    EXPERT REVIEW OF RESPIRATORY MEDICINE, 2021, 15 (06) : 737 - 744
12345